Friday August 14, 2020

Patients set to get access to promising new MS drug

The promising multiple sclerosis (MS) drug Lemtrada is set to become available to patients throughout the country.

Susan Mitchell

Deputy Editor and Health Editor

@susmitchellsbp
6th July, 2014

The promising multiple sclerosis (MS) drug Lemtrada is set to become available to patients throughout the country.

Lemtrada can reduce the effects of the disease and can, in certain cases, enable some recovery.

The National Centre for Pharmacoeconomics (NCPE), which advises the state on whether to fund new drugs, has concluded it represents value for money and is clinically effective.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 7 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago